ImmunoPrecise Antibodies Ltd. (IPA)
NASDAQ: IPA · IEX Real-Time Price · USD
1.194
-0.026 (-2.13%)
At close: Apr 25, 2024, 4:00 PM
1.240
+0.046 (3.85%)
After-hours: Apr 25, 2024, 6:36 PM EDT
ImmunoPrecise Antibodies Stock Forecast
IPA's stock price has decreased by -58.62% in the past year and price targets may not have had time to catch up.
Stock Price Forecast
The 2 analysts with 12-month price forecasts for IPA stock have an average target of 7.00, with a low estimate of 5.00 and a high estimate of 9.00. The average target predicts an increase of 486.26% from the current stock price of 1.19.
Analyst Consensus: Strong Buy
* Price targets were last updated on Mar 15, 2024.
Analyst Ratings
The average analyst rating for IPA stock from 2 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Nov '23 | Dec '23 | Jan '24 | Feb '24 | Mar '24 | Apr '24 |
|---|---|---|---|---|---|---|
| Strong Buy | 1 | 1 | 1 | 1 | 1 | 1 |
| Buy | 1 | 1 | 1 | 1 | 1 | 1 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 2 | 2 | 2 | 2 | 2 | 2 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Benchmark | Benchmark | Buy Reiterates $5 | Buy | Reiterates | $5 | +318.76% | Mar 15, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $9 | Strong Buy | Reiterates | $9 | +653.77% | Mar 15, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $9 | Strong Buy | Reiterates | $9 | +653.77% | Sep 18, 2023 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $9 | Strong Buy | Reiterates | $9 | +653.77% | Jul 12, 2023 |
| Benchmark | Benchmark | Buy Reiterates $7 | Buy | Reiterates | $7 | +486.26% | Jul 11, 2023 |
Financial Forecast
Revenue This Year
24.84M
from 20.67M
Increased by 20.18%
Revenue Next Year
30.12M
from 24.84M
Increased by 21.26%
EPS This Year
-0.48
from -1.07
EPS Next Year
-0.35
from -0.48
Revenue Forecast
| Revenue | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|---|
| High | 26.0M | 31.3M | 38.2M | 41.8M | 49.6M | 58.9M |
| Avg | 24.8M | 30.1M | 36.7M | 40.2M | 47.7M | 56.7M |
| Low | 24.0M | 29.2M | 35.7M | 39.0M | 46.3M | 55.0M |
Revenue Growth
| Revenue Growth | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|---|
| High | 25.6% | 26.1% | 26.8% | 13.8% | 23.4% | 23.4% |
| Avg | 20.2% | 21.3% | 22.0% | 9.5% | 18.7% | 18.7% |
| Low | 16.0% | 17.7% | 18.4% | 6.2% | 15.2% | 15.2% |
EPS Forecast
| EPS | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|---|
| High | -0.48 | -0.37 | -0.17 | - | 0.21 | 0.44 |
| Avg | -0.48 | -0.35 | -0.16 | - | 0.20 | 0.43 |
| Low | -0.48 | -0.34 | -0.16 | - | 0.20 | 0.41 |
EPS Growth
| EPS Growth | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|---|
| High | - | - | - | - | - | 118.4% |
| Avg | - | - | - | - | - | 110.1% |
| Low | - | - | - | - | - | 103.8% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.